clinical trials

Amplicore develops injectable therapeutics for degenerative musculoskeletal disorders, taking a regenerative approach to joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tear. Its mission is to translate scientific innovation into effective but minimally invasive products that can be easily delivered to patients.

controlled drug releaseinjectable drug formulationregenerative medicine

Anebulo Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for cannabis-induced toxicity, including acute cannabis-induced CNS depression in children and acute cannabinoid intoxication (ACI) in adults. Its lead development candidate is selonabant, a reversal agent for cannabis-induced toxicities.

drug development

Annexon Biosciences is a clinical-stage biopharmaceutical company focused on stopping C1q, the initiating molecule of the classical complement pathway, to treat autoimmune, neurodegenerative, and ophthalmic diseases of the body, brain and eye. It was co-founded by Dr. Ben Barres and Dr. Arnon Rosenthal and has a late-stage clinical pipeline of therapies targeting complement-mediated diseases.

commercialization of therapeuticstherapeutics discovery and development

Apellis Pharmaceuticals is a biopharmaceutical company that develops therapies targeting C3 to treat diseases driven by excessive activation of the complement cascade, including in hematology, ophthalmology, and nephrology. Its focus areas include geographic atrophy and rare disease. Apellis has been acquired by Biogen.

biopharmaceutical researchcomplement C3 targeted therapy development

Applied Biologics is a fully-integrated life sciences company providing research, product development, manufacturing and distribution of medical technologies. Founded in 2010, it provides doctors innovative biologic solutions and is the provider of XWRAP®, a dehydrated amniotic membrane used as a protective barrier and wound covering for acute and chronic wounds. Its GMP facility in Scottsdale, Arizona manufactures products domestically with no internationally sourced components.

aseptic recoveryCLIA-certified laboratory screeningdistributionmanufacturingproduct developmentproprietary processingresearch and development

Aquilus Pharmaceuticals is a Pre-series A biotech dedicated to developing a first-in-class medication for neurodegenerative diseases, with a primary focus on Amyotrophic Lateral Sclerosis (ALS). It has been funded via the ALS Association, NIH, and Department of Defense grants in developing a new therapeutic (AQU-118) to treat ALS. The company has completed IND enabling studies for AQU-118 and is on track toward a phase I trial in the first quarter of 2026.

drug discovery and developmentresearch and development

Arcutis Biotherapeutics is a medical dermatology company founded in 2016 that develops targeted therapies for chronic immune-driven skin diseases. Its portfolio includes ZORYVE (roflumilast) cream and ZORYVE (roflumilast) topical foam, and its pipeline includes topical roflumilast cream, topical roflumilast foam, and ARQ-234. The company is based in Westlake Village, CA, and trades on Nasdaq under the symbol ARQT.

dermatology drug developmenttopical formulation development

Argenica Therapeutics Limited (ASX:AGN) is a clinical stage drug development company developing novel neuroprotective therapeutics to reduce brain damage after stroke and other acute brain injuries. Its lead candidate ARG-007, a cationic arginine-rich peptide, is based on research from The University of Western Australia and the Perron Institute for Neurological and Translational Science. ARG-007 has completed a Phase 1 clinical trial and is being tested in a Phase 2 clinical trial in acute ischaemic stroke patients in Australia.

commercialisation of therapeuticsdrug developmentpre-clinical research

argenx is a global immunology biotech company that co-creates entrepreneurial science, bringing academic discovery, clinical insight, and patient experience together to develop medicines for severe autoimmune diseases. Its approved immunology therapies include VYVGART (efgartigimod) and VYVGART Hytrulo, and it is investigating efgartigimod, empasiprubart, and adimanebart across diseases such as myasthenia gravis, CIDP, ITP, CMS, and SMA.

co-creation with academic and clinical partnersimmunology drug discovery and development

Aromha Inc. develops the Aromha Brain Health Test (ABHT), an at-home smell test that screens for olfactory loss in adults 18 and over. The test was developed by Dr. Mark Albers, a Harvard Medical School Associate Professor of Neurology, and his team at Massachusetts General Hospital, built on over 20 years of olfactory research. It is a non-invasive at-home smell test paired with a web application, FDA-registered as a Class II medical device, 510(k) exempt.

at-home olfactory screeningolfactory research

Arsenal Medical is a medical device company that develops biomaterials-based products. Its platform includes NeoCast, an injectable shear-responsive material for deep neurovascular occlusion, and ResQFoam, a rapidly expanding hydrophobic foam designed to control hemorrhage in abdominal trauma. The company was founded by Carmichael Roberts, Robert Langer, and George Whitesides, and is led by CEO Upma Sharma.

biomaterials developmentmedical device developmentRegulatory Affairs

Arthritis Associates, PLLC is a medical practice in Hattiesburg, MS, offering specialized care for patients with arthritis, osteoporosis, and other rheumatic diseases. Services are available by physician referral only and range from testing and diagnosis to treatments including education, medicine, diet, lifestyle management, exercise, and physical therapy.

DEXA bone density testingdiagnostic x-raysphysical therapyradiographic imaging

of page ANTIBIOTIC RESISTANCEis creating an era in which common infections that used to be easily treated with penicillin and other antibiotics now routinely kill people.Atterx Biotherapeutics is introducing novel solutions to prevent and treat antibiotic-resistant infections.GN-4474: Gram Negative Bacterial Infections LEARN MOREC-1205: Catheter Associated Urinary Tract Infections LEARN MOREAnnual deaths due to antimicrobial resistance expected to rise dramatically by 2050.ABOUT ATTERX BIOTHERAPEUTICSAntibiotics are among the most commonly prescribed drugs, and have saved millions of lives since they were introduced to patients many decades ago. However, they are frequently overused and can be improperly prescribed. As a result, bacteria that were once easy to treat with antibiotics are now changing and becoming resistant to them. ​ continue reading...LATEST NEWSMay 1, 2025Atterx.

bacterial conjugation technologybacterial interference technologypharmaceutical development

Attune Biotech is the operating name of Biostax Corp, a late clinical-stage biopharmaceutical company developing Lodonal™ and JKB-122, proprietary naltrexone-based therapies built on precision dosing and modified-release formulation science. The company is developing a host-directed immune restoration platform targeting shared upstream immune and inflammatory processes across neuroimmune, inflammatory, infectious disease, and metabolic applications.

CMC packagemanufacturing controlsmodified-release formulationprecision dosing

Southeast Retina Center is a full-service diagnostic and surgical center specializing in diseases of the retina, vitreous, and macula. Using state-of-the-art technology, it offers advanced testing and treatment options, and its physicians include Dennis M. Marcus, MD, Harinderjit Singh, MD, and Tomasz Wiraszka, MD. The main office is located in Augusta, Georgia.

diagnostic testingdigital angiographyintravitreal injectionslaser treatmentsoptical coherence tomographyphotodynamic therapyretinal surgery

Austin Retina Associates is the largest group of retina specialists in Greater Austin and Central Texas, providing specialized retina care for more than 40 years. Its board-certified, fellowship-trained retina specialists diagnose and treat diseases of the retina, vitreous and macula, and the practice participates in clinical trials through its research department.

diagnostic testingeye injectionslaser therapyOptical Coherence Tomography (OCT) imagingretinal surgery

AVM Biotechnology is a clinical-stage company founded by Theresa Deisher, Ph.D., developing AVM0703, a proprietary formulation of concentrated dexamethasone that permits very high dosing to activate the release and trigger production of the body's gamma delta TCR+ invariant TCR+ bispecific T lymphocytes and Natural Killer T-like immune cells. The company targets cancer, autoimmune syndromes, acute respiratory distress syndrome (ARDS), and infectious diseases.

compassionate usedrug development

Bausch Health Companies Inc. is a global, diversified pharmaceutical company whose mission is to improve people's lives with its pharmaceutical products. It develops, manufactures and markets branded and generic pharmaceuticals and over-the-counter products in more than 90 countries and regions, with focus areas including gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health through its controlling interest in Bausch + Lomb.

manufacturingmarketingpharmaceutical developmentresearch and development

Outpatient psychiatric practice providing quality mental health services for children, adolescents, and adults. The team includes Dr. Matthew Berger, Dr. Satish Mallik, Dr. Kristie Nardell, Dr. Paul Termini, Dr. Dal Sperazza, physician assistants, psychiatric mental health nurse practitioners, and clinical counselors. Services include medication assessment and management and individual and family therapy.

ECTgenetic testingIndividual and family therapyPsychiatric medication managementpsychological testingSpravato treatmentTMSVivitrol treatment

Berlin Heals is a life science company founded in 2014 that developed the C-MIC Device, a minimally invasive cardiac implant delivering ultra-low direct current to treat heart failure. The company has conducted first-in-human studies, an international multi-center randomized controlled trial, and is enrolling a European-wide double-blind sham-controlled trial. Berlin Heals Holding Ltd. is a Swiss company operating an R&D subsidiary in Berlin, Germany.

cardiac implant developmentresearch and development

Memorial Health System operates clinics, hospitals, and health care facilities providing care to south Mississippi and the Gulf Coast. Its mission is to provide the highest quality healthcare, with services including primary care, cancer care/oncology, cardiology, neurosciences, orthopedics, walk-in care, and virtual care. The system includes Memorial Hospital Biloxi and Memorial Physician Clinics, and celebrated 80 years of care.

3D mammographybreast reconstructionchemotherapy and biotherapy infusionsCyberKnife stereotactic radiosurgerydiagnostic imagingresidency programsvirtual/telehealth visitswalk-in clinics

BioCryst is a commercial-stage global biotechnology company founded in 1986, headquartered in Durham, North Carolina, with a regional office in Boston, Massachusetts. It focuses on drug discovery, development, and commercialization of oral small-molecule and injectable protein therapeutics for hereditary angioedema (HAE) and other rare diseases.

commercializationdrug developmentdrug discovery

BioKier Inc. is an early-stage clinical-stage pharmaceutical company developing proprietary medical foods and drugs for diabetes and related disorders. Its lead product, BKR-017, is an oral capsule formulated to deliver L-glutamine to the colon to mimic the effects of bariatric-metabolic surgery and improve gut hormone secretion and regulation of glucose and lipids.

drug formulationpre-clinical researchtargeted colonic delivery

Top-seller Skincerity, the one-of-a-kind overnight breathable masque, is a product of a BDC patented technology. i Clean Mouth Rinse harnesses the power of iodine to clean where others can’t, don’t and won’t. KIOS Analytics, a breakthrough software platform, is currently under development for the management of bipolar disorder.

formulation developmentgrant writingmanufacturing with quality systems and cGMPregulatory filings (IND and 510(k))technology commercialization